BioGenCell
PrivateLast Round
Seed
May 9, 2022
Total Funding Raised
$16M
Company Overview
BioGenCell is a biotechnology company that develops personalized cell therapy treatments for degenerative microvascular diseases using its proprietary TRACT technology platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioGenCell Comparables
Compare BioGenCell with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ixaka Ltd | 84% | |
| Hemostemix | 84% | |
| Lisata Therapeutics | 79% |
BioGenCell Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 9, 2022 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 23, 2026
Monthly visitors grew 95% MoM, from 601 to 1.2K.
- Jan 8, 2026
Monthly visitors increased 83% MoM.
BioGenCell Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BioGenCell's valuation, stock price, and market status.
Is BioGenCell a public or private company?
BioGenCell is a private company.
What is the current stock price of BioGenCell?
BioGenCell is a private company, so its shares have no public market price. Caplight tracks BioGenCell's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BioGenCell worth (valuation)?
Valuation information for BioGenCell is not publicly available.
Can I buy BioGenCell stock?
BioGenCell shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BioGenCell's last funding round?
BioGenCell's most recent funding round was Seed on May 9, 2022.
Who are the main investors in BioGenCell?
Investor information for BioGenCell is not publicly disclosed.
Will BioGenCell IPO soon?
No public IPO plans have been announced for BioGenCell.
How can I track BioGenCell secondary market activity?
Caplight tracks bids, offers, and trades in BioGenCell's shares on secondary markets.